Detalles de la búsqueda
1.
Clinical Outcomes With Electronic Nudges to Increase Influenza Vaccination : A Prespecified Analysis of a Nationwide, Pragmatic, Registry-Based, Randomized Implementation Trial.
Ann Intern Med
; 177(4): 476-483, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38498876
2.
Effect of Electronic Nudges on Influenza Vaccination Rate in Older Adults With Cardiovascular Disease: Prespecified Analysis of the NUDGE-FLU Trial.
Circulation
; 147(18): 1345-1354, 2023 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36871213
3.
Electronic nudges to increase influenza vaccination uptake in Denmark: a nationwide, pragmatic, registry-based, randomised implementation trial.
Lancet
; 401(10382): 1103-1114, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36889332
4.
Effects of high-dose versus standard-dose quadrivalent influenza vaccine among patients with diabetes: A post-hoc analysis of the DANFLU-1 trial.
Diabetes Obes Metab
; 26(5): 1821-1829, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38586966
5.
Nationwide Utilization of Danish Government Electronic letter system for increasing inFLUenza vaccine uptake (NUDGE-FLU): Study protocol for a nationwide randomized implementation trial.
Am Heart J
; 260: 58-71, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36801265
6.
Influence of Digital Intervention Messaging on Influenza Vaccination Rates Among Adults With Cardiovascular Disease in the United States: Decentralized Randomized Controlled Trial.
J Med Internet Res
; 24(10): e38710, 2022 10 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36206046
7.
Effectiveness of the quadrivalent high-dose influenza vaccine for prevention of cardiovascular and respiratory events in people aged 65 years and above: Rationale and design of a real-world pragmatic randomized clinical trial.
Am Heart J
; 237: 54-61, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33722585
8.
Electronic nudges increase influenza vaccination utilization after myocardial infarction: the nationwide NUDGE-FLU implementation trial.
Eur Heart J
; 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38596844
9.
Epidemiology and burden of influenza in healthy children aged 6 to 35 months: analysis of data from the placebo arm of a phase III efficacy trial.
BMC Infect Dis
; 19(1): 308, 2019 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30947693
10.
Annual public health and economic benefits of seasonal influenza vaccination: a European estimate.
BMC Public Health
; 14: 813, 2014 Aug 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-25103091
11.
High-Dose Quadrivalent Influenza Vaccine for Prevention of Cardiovascular and Respiratory Hospitalizations in Older Adults.
Influenza Other Respir Viruses
; 18(4): e13270, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38569647
12.
Effectiveness of high-dose versus standard-dose quadrivalent influenza vaccine against recurrent hospitalizations and mortality in relation to influenza circulation: A post-hoc analysis of the DANFLU-1 randomized clinical trial.
Clin Microbiol Infect
; 2024 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38286177
13.
High-dose influenza vaccine in older adults by age and seasonal characteristics: Systematic review and meta-analysis update.
Vaccine X
; 14: 100327, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37333054
14.
Electronic nudges to increase influenza vaccination uptake among patients with heart failure: A pre-specified analysis of the NUDGE-FLU trial.
Eur J Heart Fail
; 25(8): 1450-1458, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37211967
15.
Electronically Delivered Nudges to Increase Influenza Vaccination Uptake in Older Adults With Diabetes: A Secondary Analysis of the NUDGE-FLU Trial.
JAMA Netw Open
; 6(12): e2347630, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38117499
16.
A Pragmatic Randomized Feasibility Trial of Influenza Vaccines.
NEJM Evid
; 2(2): EVIDoa2200206, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38320035
17.
Reply to letter to editor by Hadigal et al. regarding the immunogenicity and safety trial of high-dose influenza vaccine in adults aged ≥60 years.
Hum Vaccin Immunother
; 18(6): 2106749, 2022 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35914122
18.
Immunogenicity and safety of high-dose quadrivalent influenza vaccine in older adults in Taiwan: A phase III, randomized, multi-center study.
Vaccine
; 40(45): 6450-6454, 2022 10 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36216650
19.
Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies.
Hum Vaccin Immunother
; 18(6): 2132798, 2022 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36328438
20.
Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study.
Lancet Respir Med
; 10(4): 392-402, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35114141